Company: DVAX
Filing Date: 2025-04-17
Form Type: DEFC14A
Source: 0000930413-25-001273
Chunk: 82

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-04-17
Form: DEFC14A
Chunk 82
---
 of 1/3rd of the shares on the first anniversary of the vesting commencement date, with 1/36th           
 of the total number of shares vesting each month thereafter.                                                                     |
| (3)  | These RSUs were granted on February 10, 2022 and vest over three years with one-third vesting on each annual anniversary         
 date.                                                                                                                            |
| (4)  | These PSUs were granted on February 10, 2022. These PSUs vest if the Company’s relative total stockholder return                 
 ranking is equal to or greater than the 50th percentile before the end of 2024. To calculate the relative ranking, the Company’s 
 total stockholder return will be compared to the returns of the other companies comprising the Nasdaq Biotechnology Index        
 during the performance period of January 1, 2022 to December 31, 2024. No shares can vest under these awards if the Company’s    
 relative ranking is below the 50th percentile. On February 13, 2025, the Compensation Committee approved the vesting of these    
 PSUs, upon confirmation that the performance conditions had been satisfied.                                                      |
| (5)  | These PSUs were granted on February 16, 2023. These PSUs vest if the Company’s relative total stockholder return                 
 ranking is equal to or greater than the 50th percentile before the end of 2025. To calculate the relative ranking, the Company’s 
 total stockholder return will be compared to the returns of the other companies comprising the Nasdaq Biotechnology Index        
 during the performance period of January 1, 2023 to December 31, 2025. No shares can vest under these awards if the Company’s    
 relative ranking is below the 50th percentile.                                                                                   |
| (6)  | These RSUs were granted on February 15, 2024 and vest over three years with one-third vesting on each annual anniversary         
 date.                                                                                                                            |
| (7)  | These PSUs were granted on February 15, 2024. These PSUs vest if the Company’s relative total stockholder return                 
 ranking is equal to or greater than the 25th percentile before the end of 2026. To calculate the relative ranking, the Company’s 
 total stockholder return will be compared to the returns of the other companies comprising the Nasdaq Biotechnology Index        
 during the performance period of January 1, 2024